Article Details

Pfizer's (PFE) Hemophilia B Gene Therapy Meets Study Goal - December 30, 2022 - Zacks

Retrieved on: 2022-12-30 14:03:23

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's (PFE) Hemophilia B Gene Therapy Meets Study Goal - December 30, 2022 - Zacks. View article details on HISWAI: https://www.zacks.com/stock/news/2033975/pfizers-pfe-hemophilia-b-gene-therapy-meets-study-goal

Excerpt

Data from a late-stage study shows that treatment with Pfizer's (PFE) hemophilia B gene therapy resulted in a 71% reduction in annualized bleed ...

Article found on: www.zacks.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up